Pharmacy Times October 18, 2024
Key Takeaways
- New therapies must show significant clinical improvements, such as enhanced efficacy or reduced side effects, over current standards to be considered for adoption.
- Cost-effectiveness, ease of administration, and alignment with existing protocols are crucial non-clinical factors influencing treatment adoption decisions.
- The impact on healthcare resources, infrastructure, and acceptance by patients and providers are critical considerations in evaluating new therapies.
Panelists discuss how a new therapy for multiple myeloma would need to demonstrate significant improvements in...
Today's Sponsors
Today's Sponsor